152 related articles for article (PubMed ID: 15669553)
1. Breast cancer in premenopausal women: recurrence and survival rates and relationship to hormone replacement therapy.
Durna EM; Heller GZ; Leader LR; Sjoblom P; Eden JA; Wren BG
Climacteric; 2004 Sep; 7(3):284-91. PubMed ID: 15669553
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
Dew JE; Wren BG; Eden JA
Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy after a diagnosis of breast cancer: cancer recurrence and mortality.
Durna EM; Wren BG; Heller GZ; Leader LR; Sjoblom P; Eden JA
Med J Aust; 2002 Oct; 177(7):347-51. PubMed ID: 12358575
[TBL] [Abstract][Full Text] [Related]
4. A cohort study of hormone replacement therapy given to women previously treated for breast cancer.
Dew J; Eden J; Beller E; Magarey C; Schwartz P; Crea P; Wren B
Climacteric; 1998 Jun; 1(2):137-42. PubMed ID: 11907916
[TBL] [Abstract][Full Text] [Related]
5. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
[TBL] [Abstract][Full Text] [Related]
8. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
[TBL] [Abstract][Full Text] [Related]
9. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
10. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
[TBL] [Abstract][Full Text] [Related]
11. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
[TBL] [Abstract][Full Text] [Related]
14. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Ross RK; Paganini-Hill A; Wan PC; Pike MC
J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and the breast.
Dixon JM
Surg Oncol; 2003 Dec; 12(4):251-63. PubMed ID: 14998565
[TBL] [Abstract][Full Text] [Related]
16. Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer.
Bonnier P; Bessenay F; Sasco AJ; Beedassy B; Lejeune C; Romain S; Charpin C; Piana L; Martin PM
Int J Cancer; 1998 Jun; 79(3):278-82. PubMed ID: 9645351
[TBL] [Abstract][Full Text] [Related]
17. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
18. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L
Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
Nozaki M; Koera K; Nagata H; Nakano H
J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and breast cancer morbidity, mortality and recurrence.
Kenemans P; Scheele F; Burger CW
Eur J Obstet Gynecol Reprod Biol; 1997 Feb; 71(2):199-203. PubMed ID: 9138966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
